(Q46776521)

25 December 2017

title

Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture (English)

1 reference

25 December 2017

1 reference

G Gille

1

1 reference

25 December 2017

K Radad

series ordinal

2

1 reference

25 December 2017

H Reichmann

series ordinal

3

1 reference

25 December 2017

W-D Rausch

series ordinal

4

1 reference

25 December 2017

publication date

27 October 2005

1 reference

25 December 2017

Journal of Neural Transmission

published in

1 reference

25 December 2017

volume

113

1 reference

25 December 2017

issue

9

1 reference

25 December 2017

page(s)

1107-1118

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00702-005-0369-2

exact match

0 references

cites work

Neuroprotection in PD—A role for dopamine agonists?

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00702-005-0369-2

Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro

21 January 2018

1 reference

12 December 2020

Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

1 reference

12 December 2020

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

1 reference

12 December 2020

Dopamine agonists modify the course of Parkinson disease

1 reference

12 December 2020

Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.

1 reference

12 December 2020

Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

1 reference

12 December 2020

Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine.

1 reference

12 December 2020

Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.

1 reference

12 December 2020

Neuroprotection and dopamine agonists

1 reference

12 December 2020

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

12 December 2020

Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia

1 reference

12 December 2020

Dopamine receptor pharmacology

1 reference

12 December 2020

Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms

1 reference

12 December 2020

Reactive oxygen species as intracellular messengers during cell growth and differentiation

1 reference

12 December 2020

Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies

1 reference

12 December 2020

Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine.

1 reference

12 December 2020

Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde

1 reference

12 December 2020

Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells

1 reference

12 December 2020

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss

1 reference

12 December 2020

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

1 reference

12 December 2020

Dopamine receptor agonists in the therapy of Parkinson's disease.

1 reference

12 December 2020

Levodopa in the treatment of Parkinson's disease: current controversies

1 reference

12 December 2020

Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists

1 reference

12 December 2020

Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist

1 reference

12 December 2020

Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid.

1 reference

12 December 2020

Neuroprotective activity of alpha-dihydroergocryptine in animal models

1 reference

12 December 2020

An introduction to the free radical hypothesis in Parkinson's disease

1 reference

12 December 2020

Switching and combining dopamine agonists

1 reference

12 December 2020

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

1 reference

12 December 2020

Are dopamine receptor agonists neuroprotective in Parkinson's disease?

1 reference

12 December 2020

Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases

1 reference

12 December 2020

Levodopa and the progression of Parkinson's disease

1 reference

12 December 2020

Characterization of L-DOPA transport in cultured rat and mouse astrocytes

1 reference

12 December 2020

L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation.

1 reference

12 December 2020

Regulatory pathways and uptake of L-DOPA by capillary cerebral endothelial cells, astrocytes, and neuronal cells

1 reference

12 December 2020

Dopamine Synthesis, Uptake and Metabolism in Embryonic Rat Mesencephalic Cultures

1 reference

12 December 2020

Evidence for non-oxidative dopamine cytotoxicity: potent activation of NF-kappa B and lack of protection by anti-oxidants

1 reference

12 December 2020

Switching and combining of dopamine agonists

1 reference

12 December 2020

The inhibition of peroxide formation as a possible substrate for the neuroprotective action of dihydroergocryptine

1 reference

12 December 2020

Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum

1 reference

12 December 2020

Alpha-dihydroergocryptine in the long-term therapy of Parkinson's disease.

1 reference

12 December 2020

5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons

1 reference

12 December 2020

Biochemical and toxicological properties of the oxidation products of catecholamines

1 reference

12 December 2020

The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia.

1 reference

12 December 2020

Signaling by reactive oxygen species in the nervous system

1 reference

12 December 2020

Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity

1 reference

12 December 2020

Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic glia

1 reference

12 December 2020

Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: results of a multicentre, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors

1 reference

12 December 2020

Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture

1 reference

12 December 2020

Pergolide protects dopaminergic neurons in primary culture under stress conditions

1 reference

12 December 2020

Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.

1 reference

12 December 2020

L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress.

1 reference

12 December 2020

Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells.

1 reference

12 December 2020

Comparison of the neurotoxicity of dihydroxyphenylalanine stereoisomers in cultured dopamine neurons

1 reference

12 December 2020

Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.

1 reference

12 December 2020

Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones

1 reference

12 December 2020

Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease

1 reference

12 December 2020

Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture

1 reference

12 December 2020

Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine.

1 reference

12 December 2020

A synergistic neurotrophic response to l-dihydroxyphenylalanine and nerve growth factor

1 reference

12 December 2020

Both the antioxidant and D3 agonist actions of pramipexole mediate its neuroprotective actions in mesencephalic cultures.

1 reference

12 December 2020

Protection of dopaminergic neurons in primary culture by lisuride

1 reference

12 December 2020

Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor

1 reference

12 December 2020

Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

1 reference

12 December 2020

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

1 reference

12 December 2020

L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells

1 reference

12 December 2020

Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.

1 reference

12 December 2020

Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.

1 reference

12 December 2020

Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

1 reference

12 December 2020

10.1007/S00702-005-0369-2

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017